PDB31 Cost of Diabetes in Croatia Impact of Complications on the Costs of Type II Diabetes

Abstract

Association (ADA) guidelines were simulated. Cost of treatment and complications were based on officially published sources for medicines prices (www.mh.government.bg), for hospital charges (www.nhif.bg) and verified by expert opinion survey (1 BGN ϭ 0.51 EUR). Future costs were discounted with 5%. RESULTS: Treatment to targets postpones minor complications by up to 4 years, delays major complications by 3 to 4 years and extends life expectancy from diagnosis by 3 years compared with the baseline scenario. Total discounted cost savings over remaining life expectancy from the diagnosis were from 2483 BGN to 2908 BGN per person. CONCLUSIONS: Enhanced treatment leads to avoidance or delay of the complications of diabetes. This significantly reduces the impact diabetes can have on patients' quality of life, life expectancy and cost of diabetes treatment in Bulgarian health care system settings.

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

“…Study characteristics are presented in Table 1. Four studies [10,[32][33][34] reported burden-of-illness values (i.e., population-level results), whereas 20 studies [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54] reported cost-of-illness values (i.e., patient-level results). Studies from 13 countries (Brazil, Croatia, Estonia, India, Italy, Japan, Mexico, Scotland, South Korea, Spain, Sweden, the United Kingdom, and the United States) were represented in this review.…”

“…Three other studies reported on patient populations from Asia (India [44], Japan [39], and South Korea [43]). A further seven studies [33,35,40,46,47,50,52] reported results based on a European population.…”

“…‡ Weighted by population size; includes data from Croatia [33] and the United Kingdom [10]. that patients with T2DM who have been hospitalized for a cardiovascular event incur higher costs for cardiovascular care than do their nondiabetic counterparts.…”

The association of lifestyle and stress with poor glycemic control in patients with diabetes mellitus type 2: a Croatian nationwide primary care cross-sectional study

“…As such, it represents a growing burden to health economy. The total treatment cost of T2DM and its complications in Croatia amounted to 11.49% of the Croatian Health Insurance Fund’s budget in 2009, ie, to 351.7 million EUR: 50.2 million EUR for direct medical costs of diabetes treatment and monitoring, 301.5 million EUR for treatment of diabetes-related chronic complications, and 4.6 million EUR for additional indirect costs ( 2 ). It is well established that the risk of microvascular and macrovascular complications is related to glycemia.…”

Cost of severe hypoglycaemia in nine European countries

“…The total cost of type 2 DM in Croatia amounted to e351.7 million in 2009, i.e. 11.49% of the national insurer's budget 3 . This cost included e50.2 million for care and medications used directly in DM treatment (14.28%) and e301.5 million stemming from diabetes-related chronic complications (85.72%).…”